The purpose of this study was to determine if the combination of a broad spectrum MMP inhibitor (A-177430) and a selective COX-2 inhibitor (A-285969) could cooperate to reduce intestinal tumour formation in Min mice. This evidence concerns the gene PTGS2 and intestinal neoplasm.